Status:
COMPLETED
Performance of AclarusDx® a Blood-Based Transcriptomic Test for AD, in French Patients Newly Referred to a Memory Center
Lead Sponsor:
Diaxonhit
Collaborating Sponsors:
Olivier SOL, MD
Conditions:
Cognitive Impairment
Memory Complaint
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to assess the performance of AclarusDx™, an investigational blood test detecting gene expression information, and intended to help physicians in making an Alzheimer's Dise...
Detailed Description
The objective of this study is to apply AclarusDx™ signature in 600 patients newly referred in french memory centers. Only AclarusDx™ will be added to the panel of tests usually performed at the cente...
Eligibility Criteria
Inclusion
- male and female adult patients
- suffering from cognitive impairment and/or memory complaint and justifying a first clinical investigation at the memory center
Exclusion
- patient already followed up by the memory center
- patient unable to comply with study procedures
Key Trial Info
Start Date :
December 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
606 Patients enrolled
Trial Details
Trial ID
NCT02221661
Start Date
December 1 2011
End Date
December 1 2013
Last Update
August 22 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.